CDNA

CareDx, Inc.

12.06 USD
+0.05 (+0.42%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Government Trades

The Stock Trading on Congressional Knowledge Act requires U.S. Senators and U.S. Representatives to publicly file and disclose any financial transaction within 45 days of its occurrence. We download those disclosures, parse them for stock trades, fetch the stock's performance in the time following the transaction, and calculate each politician's cumulative return from their trades.

Government Trades
Stock Politician Transaction Excess return * Traded Filed
CDNA
Caredx, Inc.
Daniel Goldman
D  House
Sale
$1,001 - $15,000
  -20.87%
Mar 6, 2023
Apr 17, 2023
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Sale
$1,001 - $15,000
  -107.87%
Jan 11, 2021
Aug 26, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Sale
$1,001 - $15,000
  -107.10%
Jan 8, 2021
Aug 26, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Sale
$15,001 - $50,000
  -108.28%
Jan 6, 2021
Aug 26, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Purchase
$1,001 - $15,000
  -109.01%
Dec 29, 2020
Aug 26, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Purchase
$1,001 - $15,000
  -110.86%
Dec 23, 2020
Aug 26, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Purchase
$1,001 - $15,000
  -108.69%
Dec 7, 2020
Aug 26, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Purchase
$1,001 - $15,000
  -107.69%
Nov 16, 2020
Aug 26, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Sale
$1,001 - $15,000
  -113.01%
Oct 9, 2020
Aug 26, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Purchase
$15,001 - $50,000
  -105.82%
Mar 2, 2021
Apr 10, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Sale
$1,001 - $15,000
  -130.61%
Jun 19, 2019
Mar 5, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Sale
$1,001 - $15,000
  -131.60%
Jun 17, 2019
Mar 5, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Purchase
$1,001 - $15,000
  -127.78%
Apr 1, 2019
Mar 5, 2021
CDNA
Caredx, Inc.
Tom Malinowski
D  House
Sale
$15,001 - $50,000
  -135.10%
Mar 11, 2019
Mar 5, 2021

* Estimated excess return of the underlying stock since the transaction